{"id":1209,"date":"2023-01-11T15:14:57","date_gmt":"2023-01-11T14:14:57","guid":{"rendered":"https:\/\/acare-network.com\/?page_id=1209"},"modified":"2024-04-12T18:26:20","modified_gmt":"2024-04-12T16:26:20","slug":"all-things-angioedema-podcast","status":"publish","type":"page","link":"https:\/\/acare-network.com\/all-things-angioedema-podcast\/","title":{"rendered":"All Things Angioedema Podcast"},"content":{"rendered":"

\"ATA<\/span><\/div><\/div><\/div>

The ACARE LevelUp Podcast series planned as All Things Angioedema, will be launched in as a 36 episode series with a new episode being published every 2 weeks. All things Urticaria<\/a> has been one of the most successful formats in the UCARE LevelUp program, with more than 50 episodes and 10 thousand listeners in the 18-month period.<\/span><\/p>\n

All Things Angioedema podcast episodes will be approximately 15 minute long and will be hosted by Dr. Thomas Buttgereit (Germany), one of the stars of the ACARE network. They will talk to physicians, patient organizations and people of interest in the angioedema community from around the world to teach listeners all the ins-and-outs of angioedema.<\/p>\n

If you have any suggestions for future podcast topics or comments, please reach out to Rebekka Locke<\/strong> at rebekka.lockeATga2len.berlin.<\/p>\n

If you have any questions on technical issues, please reach out to Becky Bradley <\/b>at EPG Health at becky.bradleyATepghealth.com<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div>
<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 16 \u2013 ACE inhibitor-induced angioedema<\/span><\/a><\/h4><\/div>
\n

Ear, nose and throat specialist Dr Robin Lochbaum joins Dr Thomas Buttgereit to discuss angiotensin-converting enzyme (ACE) inhibitor\u2011induced angioedema, including information on the incidence and mechanism of action, and antihypertensive treatment options.<\/p>\n

Listen on Apple Podcasts<\/a><\/b> or Spotify<\/a><\/b><\/p>\n

For more information about the GA2LEN ACARE network and its activities please visit https:\/\/acare-network.com\/<\/a>. Additional resources relating to the topics discussed in this episode can be found here: Concomitant medication in patients with bradykinin-mediated angioedema \u2013 there\u2019s more than ACE inhibitors<\/a>; The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema<\/a>; and Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors \u2013 a nationwide registry-based cohort study<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 15 \u2013 Mast cell-mediated angioedema<\/span><\/a><\/h4><\/div>
\n

\u201cShould it be considered a part of chronic spontaneous urticaria?\u201d Dr Thomas Buttgereit welcomes Dr Marta Ferrer Puga to talk about mast cell-mediated angioedema, including discussion of the international urticaria guidelines definition.<\/p>\n

Listen on Apple Podcast<\/a> or Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here<\/a>.<\/p>\n

For more information about the GA2LEN ACARE network and its activities please visit https:\/\/acare-network.com\/.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 14 \u2013 Collaboration in HAE<\/span><\/a><\/h4><\/div>
\n

\u201cThere are a lot of doctors that should know about angioedema.\u201d Ear, nose and throat specialist Dr Janina Hahn joins Dr Thomas Buttgereit to discuss the importance of implementing an interdisciplinary approach in HAE, including tips on overcoming challenges.<\/p>\n

Listen on Apple Podcast<\/a> or Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here<\/a>.<\/p>\n

For more information about the GA2LEN ACARE network and its activities please visit https:\/\/acare-network.com\/.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 13 \u2013 Angioedema in the paediatric population<\/span><\/a><\/h4><\/div>
\n

\u201cChildren should be informed about their illness according to their age.\u201d Professor Henriette Farkas joins Dr Thomas Buttgereit to discuss angioedema in children, covering acute treatment options and the differing symptoms between adults and children.<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2LEN ACARE network and its activities please visit https:\/\/acare-network.com\/. Additional resources relating to the topics discussed in this episode can be found here:\u00a0P-49 Transmission patterns in C1-INH deficiency Hereditary Angioedema favours a wild-type male offspring: our experience at Chandigarh, India<\/a>;\u00a0Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent<\/a>;\u00a0Screening for type II hereditary angioedema<\/a>;\u00a0Transmission patterns of C1-INH deficiency hereditary angioedema favours a wild-type male offspring<\/a>\u00a0and\u00a0Epidemiology, management and treatment access of hereditary angioedema in the Asia pacific region<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 12 \u2013 The HAE specialist: \u2018Never give up\u2019<\/span><\/a><\/h4><\/div>
\n

\u201cI want to take an extra step, just to make sure that we never give up and provide them with the care that they deserve to receive.\u201d Dr Danny Cohn joins Dr Thomas Buttgereit to talk about the role of an HAE specialist providing long-term, often multigenerational care, including the benefits offered by ACARE centres.<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2LEN ACARE network and its activities please visit https:\/\/acare-network.com\/. Additional resources relating to the topics discussed in this episode can be found here:\u00a0P-49 Transmission patterns in C1-INH deficiency Hereditary Angioedema favours a wild-type male offspring: our experience at Chandigarh, India<\/a>;\u00a0Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent<\/a>;\u00a0Screening for type II hereditary angioedema<\/a>;\u00a0Transmission patterns of C1-INH deficiency hereditary angioedema favours a wild-type male offspring<\/a>\u00a0and\u00a0Epidemiology, management and treatment access of hereditary angioedema in the Asia pacific region<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 11 - The perspective from India in treating paediatric patients<\/span><\/a><\/h4><\/div>
\n

Dr Thomas Buttgereit is joined by Professor Ankur Kumar Jindal to discuss his experience as a paediatrician treating angioedema in India, covering the reoccurring challenges and how best to counsel families when discussing the risk of transmission to the next generation.<\/p>\n

Listen on Apple Podcast<\/a> or Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2LEN ACARE network and its activities please visit https:\/\/acare-network.com\/. Additional resources relating to the topics discussed in this episode can be found here:\u00a0P-49 Transmission patterns in C1-INH deficiency Hereditary Angioedema favours a wild-type male offspring: our experience at Chandigarh, India<\/a>;\u00a0Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent<\/a>;\u00a0Screening for type II hereditary angioedema<\/a>;\u00a0Transmission patterns of C1-INH deficiency hereditary angioedema favours a wild-type male offspring<\/a>\u00a0and\u00a0Epidemiology, management and treatment access of hereditary angioedema in the Asia pacific region<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 10 - Who is behind the scenes of ACARE?<\/span><\/a><\/h4><\/div>
\n

Dr Thomas Buttgereit is joined by Julia F\u00f6ll and Reinhardt Britz to discuss the responsibilities of working within an ACARE office, covering audit criteria and ongoing ACARE projects.<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>. Additional resources relating to the topics discussed in this episode can be found here:\u00a0Become an ACARE<\/a>,\u00a0ACARE LevelUp: The ACARE physician information and education platform<\/a>\u00a0and\u00a0Programme for the identification of mutations in genes of patients with recurrent idiopathic or hereditary angioedema<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 9 - The AURORA study<\/span><\/a><\/h4><\/div>
\n

\u201cIn the past, they\u2019ve used 72\u00a0different combinations of outcomes and outcome measures.\u201d Remy Peterson joins Dr Thomas Buttgereit to discuss the need for the AURORA study, and shares the resulting consensus for acute treatment outcomes in hereditary angioedema (HAE).<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 8 - The future of angioedema: Is there a cure on the horizon?<\/span><\/a><\/h4><\/div>
\n

Join Dr Laur\u00e9 Fijen and Dr Thomas Buttgereit as they discuss emerging angioedema treatments, covering efficacy, safety, frequency and route of administration. The experts also reflect on the possibility of a cure for hereditary angioedema (HAE).<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 7 - Treating hereditary angioedema<\/span><\/a><\/h4><\/div>
\n

Join Professor Anna Valerieva and Dr Thomas Buttgereit as they discuss the burden of living with rare forms of angioedema, particularly hereditary angioedema (HAE). Drawing from her expertise as an allergologist at the Medical University of Sofia, Bulgaria, Professor Valerieva emphasises the importance of viewing patients holistically and considering their preferences. The experts also review how the introduction of new treatments has changed patients\u2019 lives and minimised recurrent angioedema attacks.<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 6 - Tackling acquired angioedema and related comorbidities<\/span><\/a><\/h4><\/div>
\n

Join Dr Andrea Zanichelli and Dr Thomas Buttgereit as they discuss complex angioedema cases, including acquired angioedema diagnosed in later life. Drawing from his perspective as Head of the Angioedema Center in Milan, Italy, Dr Zanichelli explores how C1 and C4\u00a0inhibitor deficiencies may indicate a possible acquired angioedema diagnosis, common comorbidities due to this condition, and the current treatment options available.<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 5 - An ENT view of angioedema<\/span><\/a><\/h4><\/div>
\n

Join Dr. Antonia Scherer and Dr. Thomas Buttgereit as they discuss the impact of recurrent hereditary angioedema on the larynx. Drawing from her perspective as an ENT expert, Dr Scherer explores how laryngeal angioedema is assessed in the clinic, and the current treatment options available.<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 4 - Androgens in hereditary angioedema<\/span><\/a><\/h4><\/div>
\n

Dr Thomas Buttgereit is joined by Dr Carolina Vera to discuss the use of attenuated androgens in the treatment of hereditary angioedema and their associated risks and side effects. Both exerts delve into the safety, ethical considerations and alternative treatment options to using androgens for the treatment of hereditary angioedema. Dr Vera concludes the discussion with an in-depth explanation of the SHAERPA project, focusing on the discontinuation of androgen use in individuals with angioedema, and the benefits this project can have in providing guidance on alternative medications.<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 3 - Angioedema and EAACI 2023<\/span><\/a><\/h4><\/div>
\n

Professor Jason Fok joins Dr Thomas Buttgereit to discuss angioedema updates from the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2023 and the role EAACI has in disseminating novel insights in angioedema treatment and diagnosis. Dr Buttgereit takes a deep dive into how data presented at EAACI congresses can be implemented into specialist ACARE clinics and the benefits the congress has in aiding clinicians to implement the latest guidelines for the benefit of patients.<\/p>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 2 - What is angioedema and what is not?<\/span><\/a><\/h4><\/div>
\n
Dr Thomas Buttgereit is joined by Professor Markus Magerl, leader of the angioedema clinics at ACARE Berlin. Their conversation explores the clinical features of recurrent angioedema and the essential differential diagnoses that dermatologists must bear in mind when encountering facial swellings.<\/div>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div>

<\/i><\/i><\/span>Episode 1 - What \u201cangioedemologists\u201d do and what motivates them<\/span><\/a><\/h4><\/div>
\n
\n
Welcome to our first episode of the\u00a0All Things Angioedema \u2013 Learning about Angioedema<\/strong>\u00a0with Dr. Thomas Buttgereit Podcast<\/div>\n
<\/div>\n
Dr Thomas Buttgereit welcomes the renowned urticaria specialist, Professor Marcus Maurer. Professor Maurer is the founding force behind both ACARE and UCARE, and spearheads the popular podcast, All Things Urticaria. The pair delve into the significance of angioedema across all areas of medicine and offer insights into the role and responsibilities of angioedemologists. They also shed light on the complexities of tackling angioedema, highlighting the invaluable role of the ACARE global network in tackling these challenges.<\/div>\n<\/div>\n

Listen on\u00a0Apple Podcast<\/a>\u00a0or\u00a0Spotify<\/a>.<\/p>\n

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection\u00a0here<\/a>.<\/p>\n

For more information about the GA2<\/sup>LEN ACARE network and its activities please visit\u00a0https:\/\/acare-network.com\/<\/a>.<\/p>\n

Additional resources relating to the topics discussed in this episode can be found here:\u00a0The registered study protocol: AcUte tReatment Outcomes in heReditary Angioedema (AURORA)<\/a>\u00a0and\u00a0Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review<\/a>.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"yoast_head":"\nAll Things Angioedema Podcast - ACARE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/acare-network.com\/all-things-angioedema-podcast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"All Things Angioedema Podcast - ACARE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/acare-network.com\/all-things-angioedema-podcast\/\" \/>\n<meta property=\"og:site_name\" content=\"ACARE\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-12T16:26:20+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/acare-network.com\/all-things-angioedema-podcast\/\",\"url\":\"https:\/\/acare-network.com\/all-things-angioedema-podcast\/\",\"name\":\"All Things Angioedema Podcast - ACARE\",\"isPartOf\":{\"@id\":\"https:\/\/acare-network.com\/#website\"},\"datePublished\":\"2023-01-11T14:14:57+00:00\",\"dateModified\":\"2024-04-12T16:26:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/acare-network.com\/all-things-angioedema-podcast\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/acare-network.com\/all-things-angioedema-podcast\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/acare-network.com\/all-things-angioedema-podcast\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/acare-network.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"All Things Angioedema Podcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/acare-network.com\/#website\",\"url\":\"https:\/\/acare-network.com\/\",\"name\":\"ACARE\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/acare-network.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/acare-network.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/acare-network.com\/#organization\",\"name\":\"ACARE\",\"url\":\"https:\/\/acare-network.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/acare-network.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/acare-network.com\/wp-content\/uploads\/2022\/06\/acare-logo_final.svg\",\"contentUrl\":\"https:\/\/acare-network.com\/wp-content\/uploads\/2022\/06\/acare-logo_final.svg\",\"width\":644,\"height\":264,\"caption\":\"ACARE\"},\"image\":{\"@id\":\"https:\/\/acare-network.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"All Things Angioedema Podcast - ACARE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/acare-network.com\/all-things-angioedema-podcast\/","og_locale":"en_US","og_type":"article","og_title":"All Things Angioedema Podcast - ACARE","og_url":"https:\/\/acare-network.com\/all-things-angioedema-podcast\/","og_site_name":"ACARE","article_modified_time":"2024-04-12T16:26:20+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/acare-network.com\/all-things-angioedema-podcast\/","url":"https:\/\/acare-network.com\/all-things-angioedema-podcast\/","name":"All Things Angioedema Podcast - ACARE","isPartOf":{"@id":"https:\/\/acare-network.com\/#website"},"datePublished":"2023-01-11T14:14:57+00:00","dateModified":"2024-04-12T16:26:20+00:00","breadcrumb":{"@id":"https:\/\/acare-network.com\/all-things-angioedema-podcast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/acare-network.com\/all-things-angioedema-podcast\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/acare-network.com\/all-things-angioedema-podcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/acare-network.com\/"},{"@type":"ListItem","position":2,"name":"All Things Angioedema Podcast"}]},{"@type":"WebSite","@id":"https:\/\/acare-network.com\/#website","url":"https:\/\/acare-network.com\/","name":"ACARE","description":"","publisher":{"@id":"https:\/\/acare-network.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/acare-network.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/acare-network.com\/#organization","name":"ACARE","url":"https:\/\/acare-network.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/acare-network.com\/#\/schema\/logo\/image\/","url":"https:\/\/acare-network.com\/wp-content\/uploads\/2022\/06\/acare-logo_final.svg","contentUrl":"https:\/\/acare-network.com\/wp-content\/uploads\/2022\/06\/acare-logo_final.svg","width":644,"height":264,"caption":"ACARE"},"image":{"@id":"https:\/\/acare-network.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/acare-network.com\/wp-json\/wp\/v2\/pages\/1209"}],"collection":[{"href":"https:\/\/acare-network.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/acare-network.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/acare-network.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/acare-network.com\/wp-json\/wp\/v2\/comments?post=1209"}],"version-history":[{"count":18,"href":"https:\/\/acare-network.com\/wp-json\/wp\/v2\/pages\/1209\/revisions"}],"predecessor-version":[{"id":1949,"href":"https:\/\/acare-network.com\/wp-json\/wp\/v2\/pages\/1209\/revisions\/1949"}],"wp:attachment":[{"href":"https:\/\/acare-network.com\/wp-json\/wp\/v2\/media?parent=1209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}